| Phase 2 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT06342466 | Bortezomib, Pomalidomide, Dexamethasone for Systemic AL Amyloidosis | Systemic Amyloidosis | Recruiting | 2024-12-30 |
| Not applicable | ||||
| NCT06192979 | Optimize First-line Treatment for AL Amyloidosis With t (11; 14) | Amyloidosis; Systemic | Recruiting | 2026-07-07 |
Amyloidosis (2)